Recombinant Human MIP-3 (CCL23)
Catalog No : IGX-RP644
324.56€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | Recombinant Human MIP-3 (CCL23) | ||
|---|---|---|---|
| Catalog No | IGX-RP644 | ||
| Supplier’s Catalog No | IGX-RP644 | ||
| Supplier | ImuGeX | ||
| Source antigen | E. coli | ||
| Reactivity | Human | ||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 11 | ||
| Storage | -70°C | ||
|---|---|---|---|
| Other names | CK-beta-8, CKB-8, MIP3, Myeloid progenitor inhibitory factor 1, MPIF-1, Small-inducible cytokine A23, MIP3, MPIF1, SCYA23, CCL23, C-C motif chemokine 23<br/>Recombinant Human Macrophage Inflammatory Protein-3 (CCL23) | ||
| Grade | Highly Purified | ||
| Purity | >95% as determined by SDS-PAGE | ||
| Form | Recombinant CCL23 was lyophilized from a 0.2 μm filtered 20 mM PB, 100 mM NaCl solution pH 7.5. | ||
| Reactivity life | 6 months | ||
| Note | For reserch purpose only | ||
| Purity | >95% as determined by SDS-PAGE | ||
| Description | CCL23 (MPIF-1, CK8, SCYA23), a member of the CC chemokine family, was originally isolated from a human aortic endothelial cell library and from the human monocytic cell line THP-1. It is most closely related to MIP-1 and interacts with its receptor CCR1, which is expressed on monocytes, dendritic cells, lymphocytes, and endothelial cells. Functionally, CCL23 has chemotactic activity for monocytes, DC, lymphocytes, neutrophils, osteoclast precursor cells, and endothelial cells. In contrast, CCL23 reduces the proliferation of progenitor cells giving rise to granulocyte and monocyte lineages, whereas it enhances angiogenesis of endothelial cells | ||
Product Details
© 2020 Imugex All Rights Reserved